StemWave Unveils Platinum Provider Program
Boston – Feb 05, 2024 – StemWave, a trailblazer in non-invasive regenerative technology, is proud to introduce its latest initiative, the Platinum Provider Program. This comprehensive program is an extension and upgrade to StemWave’s existing education program, designed to empower clients and providers with essential knowledge in business, clinical information about the technology, and strategic marketing […]
StemWave and Rehab Management Group Forge Exclusive Partnership to Revolutionize Orthopedic Care
BOSTON, MASSACHUSETTS, UNITED STATES OF AMERICA, August 17, 2023/EINPresswire.com/ — – StemWave, a pioneering medical device company specializing in innovative orthopedic focused wave technology, is thrilled to announce an exclusive partnership with Rehab Management Group, a leading provider of comprehensive rehabilitation solutions. This groundbreaking collaboration aims to transform orthopedic care across the United States by […]
StemWave Among Startups From MA Make 2023 Inc. List Of Fastest-Growing Companies
MASSACHUSETTS — Several startups with roots in Massachusetts are worth keeping an eye on as they respond to some of the nation’s most vexing problems, Inc. magazine said with the release of its 2023 Inc. 5000 list. The startup companies were ranked by revenue growth from 2019 to 2022. To be considered, they had to have earned […]
StemWave Partners with Inceler Medikal As Exclusive North America Distributor for Newly Developed Acoustic Wave Technology
April 27, 2022 – StemWave introduces a new partnership as the exclusive distributor for North America with global acoustic-wave manufacturer, Inceler Medikal. Inceler Medikal is a world-leading acoustic-wave manufacturer and researcher based in Turkey, that has eagerly seeked market access to North America. The StemWave executive team has years of experience in the commercialization of acoustic-wave […]
StemWave Introduces Modus-F, A New FDA Listed Device With Cellular Response Therapy (CRT) Now Available For Orthopedic Use
March 28, 2022 – StemWave recently announced that their newest device Modus-F is now available for sale. StemWave recently received a Class l listing from the FDA and announced an exclusive North American partnership with Inceler Medikal, a leading global manufacturer. StemWave’s newest product, Modus-F, uses uniquely designed Cellular Response Therapy (CRT) which utilizes an […]
